# Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-effectiveness-and-safety-of-infliximab-golimumab-and-ustekinumab-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Proton Rahman,R. Arendse,Majed Khraishi,D. Sholter,M. Sheriff,Emmanouil Rampakakis,A.J. Lehman,F. Nantel |
| Citations | 10 |
| DOI | 10.1136/bmjopen-2019-036245 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmjopen.bmj.com/content/bmjopen/10/8/e036245.full.pdf |
| OpenAlex ID | https://openalex.org/W3048606852 |
| PMID | 32792436 |
| Type | article |
| Year | 2020 |

## Paper authors

- [D. Sholter](https://scholariq.org/researchers/d-sholter/)

## Paper journal

- [BMJ Open](https://scholariq.org/journals/bmj-open/)

## Paper primary topic

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Paper topics

- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.